Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
RUNX1
|
ENSG00000159216.14 | RUNX family transcription factor 1 |
RUNX2
|
ENSG00000124813.16 | RUNX family transcription factor 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
RUNX1 | hg19_v2_chr21_-_36421401_36421462 | 0.54 | 1.6e-03 | Click! |
RUNX2 | hg19_v2_chr6_+_45389893_45389914 | 0.53 | 1.8e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_60739249 | 15.50 |
ENST00000542157.1
ENST00000433107.2 ENST00000452451.2 ENST00000352009.5 |
CD6
|
CD6 molecule |
chr11_+_60739115 | 14.85 |
ENST00000344028.5
ENST00000346437.4 |
CD6
|
CD6 molecule |
chr2_+_7865923 | 14.51 |
ENST00000417930.1
|
AC092580.4
|
AC092580.4 |
chr2_-_89442621 | 14.36 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
chrX_-_70838306 | 13.66 |
ENST00000373691.4
ENST00000373693.3 |
CXCR3
|
chemokine (C-X-C motif) receptor 3 |
chr11_+_60739140 | 12.97 |
ENST00000313421.7
|
CD6
|
CD6 molecule |
chr1_+_159770292 | 12.70 |
ENST00000536257.1
ENST00000321935.6 |
FCRL6
|
Fc receptor-like 6 |
chr12_-_68553512 | 12.34 |
ENST00000229135.3
|
IFNG
|
interferon, gamma |
chr1_-_114414316 | 11.96 |
ENST00000528414.1
ENST00000538253.1 ENST00000460620.1 ENST00000420377.2 ENST00000525799.1 ENST00000359785.5 |
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
chr1_+_209929377 | 11.56 |
ENST00000400959.3
ENST00000367025.3 |
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr2_+_90077680 | 11.29 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
chr16_+_85942594 | 11.20 |
ENST00000566369.1
|
IRF8
|
interferon regulatory factor 8 |
chr22_+_23114284 | 11.13 |
ENST00000390313.2
|
IGLV3-12
|
immunoglobulin lambda variable 3-12 |
chr1_+_209929494 | 11.08 |
ENST00000367026.3
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr17_-_46262541 | 10.24 |
ENST00000579336.1
|
SKAP1
|
src kinase associated phosphoprotein 1 |
chr1_+_209929446 | 10.11 |
ENST00000479796.1
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
chrX_-_49121165 | 9.99 |
ENST00000376207.4
ENST00000376199.2 |
FOXP3
|
forkhead box P3 |
chr17_-_29641084 | 9.91 |
ENST00000544462.1
|
EVI2B
|
ecotropic viral integration site 2B |
chr17_-_29641104 | 9.88 |
ENST00000577894.1
ENST00000330927.4 |
EVI2B
|
ecotropic viral integration site 2B |
chr17_-_34417479 | 9.53 |
ENST00000225245.5
|
CCL3
|
chemokine (C-C motif) ligand 3 |
chr6_-_41168920 | 9.52 |
ENST00000483722.1
|
TREML2
|
triggering receptor expressed on myeloid cells-like 2 |
chr3_-_71834207 | 9.34 |
ENST00000295619.3
|
PROK2
|
prokineticin 2 |
chr1_+_198608292 | 9.05 |
ENST00000418674.1
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
chr2_-_158300556 | 9.01 |
ENST00000264192.3
|
CYTIP
|
cytohesin 1 interacting protein |
chr5_-_39219705 | 8.88 |
ENST00000351578.6
|
FYB
|
FYN binding protein |
chr12_-_53594227 | 8.81 |
ENST00000550743.2
|
ITGB7
|
integrin, beta 7 |
chr1_+_198608146 | 8.74 |
ENST00000367376.2
ENST00000352140.3 ENST00000594404.1 ENST00000598951.1 ENST00000530727.1 ENST00000442510.2 ENST00000367367.4 ENST00000348564.6 ENST00000367364.1 ENST00000413409.2 |
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
chr5_-_39219641 | 8.74 |
ENST00000509072.1
ENST00000504542.1 ENST00000505428.1 ENST00000506557.1 |
FYB
|
FYN binding protein |
chr14_+_22180536 | 8.67 |
ENST00000390424.2
|
TRAV2
|
T cell receptor alpha variable 2 |
chr6_+_31543334 | 8.65 |
ENST00000449264.2
|
TNF
|
tumor necrosis factor |
chr14_-_106312010 | 8.51 |
ENST00000390556.2
|
IGHD
|
immunoglobulin heavy constant delta |
chr1_-_25291475 | 8.51 |
ENST00000338888.3
ENST00000399916.1 |
RUNX3
|
runt-related transcription factor 3 |
chr5_+_35856951 | 8.47 |
ENST00000303115.3
ENST00000343305.4 ENST00000506850.1 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
chr19_-_54804173 | 8.37 |
ENST00000391744.3
ENST00000251390.3 |
LILRA3
|
leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 |
chr12_+_129338008 | 8.25 |
ENST00000442111.2
ENST00000281703.6 |
GLT1D1
|
glycosyltransferase 1 domain containing 1 |
chr4_-_84035868 | 8.22 |
ENST00000426923.2
ENST00000509973.1 |
PLAC8
|
placenta-specific 8 |
chr8_-_134072593 | 8.18 |
ENST00000427060.2
|
SLA
|
Src-like-adaptor |
chr16_+_29674540 | 8.03 |
ENST00000436527.1
ENST00000360121.3 ENST00000449759.1 |
SPN
QPRT
|
sialophorin quinolinate phosphoribosyltransferase |
chr2_+_204571198 | 8.02 |
ENST00000374481.3
ENST00000458610.2 ENST00000324106.8 |
CD28
|
CD28 molecule |
chr1_+_172628154 | 7.86 |
ENST00000340030.3
ENST00000367721.2 |
FASLG
|
Fas ligand (TNF superfamily, member 6) |
chr2_+_204571375 | 7.74 |
ENST00000374478.4
|
CD28
|
CD28 molecule |
chr16_+_31366455 | 7.74 |
ENST00000268296.4
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit) |
chr4_-_84035905 | 7.55 |
ENST00000311507.4
|
PLAC8
|
placenta-specific 8 |
chr17_-_34524157 | 7.55 |
ENST00000378354.4
ENST00000394484.1 |
CCL3L3
|
chemokine (C-C motif) ligand 3-like 3 |
chr1_-_168513229 | 7.50 |
ENST00000367819.2
|
XCL2
|
chemokine (C motif) ligand 2 |
chr14_-_25103472 | 7.43 |
ENST00000216341.4
ENST00000382542.1 ENST00000382540.1 |
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
chr19_-_8567505 | 7.43 |
ENST00000600262.1
|
PRAM1
|
PML-RARA regulated adaptor molecule 1 |
chr7_+_142012967 | 7.39 |
ENST00000390357.3
|
TRBV4-1
|
T cell receptor beta variable 4-1 |
chr14_-_25078864 | 7.39 |
ENST00000216338.4
ENST00000557220.2 ENST00000382548.4 |
GZMH
|
granzyme H (cathepsin G-like 2, protein h-CCPX) |
chr5_-_39203093 | 7.36 |
ENST00000515010.1
|
FYB
|
FYN binding protein |
chr3_-_72150076 | 7.36 |
ENST00000488545.1
ENST00000608654.1 |
LINC00877
|
long intergenic non-protein coding RNA 877 |
chr1_+_203734296 | 7.32 |
ENST00000442561.2
ENST00000367217.5 |
LAX1
|
lymphocyte transmembrane adaptor 1 |
chr8_-_126963387 | 7.29 |
ENST00000522865.1
ENST00000517869.1 |
LINC00861
|
long intergenic non-protein coding RNA 861 |
chr1_-_92951607 | 7.28 |
ENST00000427103.1
|
GFI1
|
growth factor independent 1 transcription repressor |
chr19_-_51875894 | 7.21 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
chr19_-_36233332 | 7.20 |
ENST00000592537.1
ENST00000246532.1 ENST00000344990.3 ENST00000588992.1 |
IGFLR1
|
IGF-like family receptor 1 |
chr16_+_29674277 | 7.20 |
ENST00000395389.2
|
SPN
|
sialophorin |
chr14_+_22508822 | 7.01 |
ENST00000390448.3
|
TRAV20
|
T cell receptor alpha variable 20 |
chr14_-_50506589 | 7.01 |
ENST00000553914.2
|
RP11-58E21.3
|
RP11-58E21.3 |
chr22_+_22453093 | 6.98 |
ENST00000390283.2
|
IGLV8-61
|
immunoglobulin lambda variable 8-61 |
chr17_-_73839792 | 6.98 |
ENST00000590762.1
|
UNC13D
|
unc-13 homolog D (C. elegans) |
chr19_-_8567478 | 6.91 |
ENST00000255612.3
|
PRAM1
|
PML-RARA regulated adaptor molecule 1 |
chr3_-_150920979 | 6.91 |
ENST00000309180.5
ENST00000480322.1 |
GPR171
|
G protein-coupled receptor 171 |
chr14_+_22573582 | 6.88 |
ENST00000390453.1
|
TRAV24
|
T cell receptor alpha variable 24 |
chr14_+_22337014 | 6.87 |
ENST00000390436.2
|
TRAV13-1
|
T cell receptor alpha variable 13-1 |
chr8_-_126963487 | 6.75 |
ENST00000518964.1
|
LINC00861
|
long intergenic non-protein coding RNA 861 |
chr17_-_62009621 | 6.73 |
ENST00000349817.2
ENST00000392795.3 |
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
chr6_-_128222103 | 6.67 |
ENST00000434358.1
ENST00000543064.1 ENST00000368248.2 |
THEMIS
|
thymocyte selection associated |
chr16_-_68033356 | 6.63 |
ENST00000393847.1
ENST00000573808.1 ENST00000572624.1 |
DPEP2
|
dipeptidase 2 |
chr4_+_71091786 | 6.62 |
ENST00000317987.5
|
FDCSP
|
follicular dendritic cell secreted protein |
chr14_-_25103388 | 6.60 |
ENST00000526004.1
ENST00000415355.3 |
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
chr17_-_34625719 | 6.57 |
ENST00000422211.2
ENST00000542124.1 |
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1 |
chr14_+_22748980 | 6.56 |
ENST00000390465.2
|
TRAV38-2DV8
|
T cell receptor alpha variable 38-2/delta variable 8 |
chr6_+_27925019 | 6.55 |
ENST00000244623.1
|
OR2B6
|
olfactory receptor, family 2, subfamily B, member 6 |
chr22_+_22385332 | 6.51 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr1_+_17634689 | 6.45 |
ENST00000375453.1
ENST00000375448.4 |
PADI4
|
peptidyl arginine deiminase, type IV |
chr22_+_23247030 | 6.44 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr1_-_153517473 | 6.38 |
ENST00000368715.1
|
S100A4
|
S100 calcium binding protein A4 |
chr19_+_7413835 | 6.35 |
ENST00000576789.1
|
CTB-133G6.1
|
CTB-133G6.1 |
chr16_-_3306587 | 6.35 |
ENST00000541159.1
ENST00000536379.1 ENST00000219596.1 ENST00000339854.4 |
MEFV
|
Mediterranean fever |
chr8_+_22435762 | 6.34 |
ENST00000456545.1
|
PDLIM2
|
PDZ and LIM domain 2 (mystique) |
chr20_-_1600642 | 6.32 |
ENST00000381603.3
ENST00000381605.4 ENST00000279477.7 ENST00000568365.1 ENST00000564763.1 |
SIRPB1
RP4-576H24.4
|
signal-regulatory protein beta 1 Uncharacterized protein |
chr5_-_149465990 | 6.22 |
ENST00000543093.1
|
CSF1R
|
colony stimulating factor 1 receptor |
chr22_+_23063100 | 6.21 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
chr16_+_23847267 | 6.15 |
ENST00000321728.7
|
PRKCB
|
protein kinase C, beta |
chr8_+_11351876 | 6.08 |
ENST00000529894.1
|
BLK
|
B lymphoid tyrosine kinase |
chr12_-_109025849 | 6.08 |
ENST00000228463.6
|
SELPLG
|
selectin P ligand |
chr16_+_23847339 | 6.02 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
chr11_+_4470525 | 6.00 |
ENST00000325719.4
|
OR52K2
|
olfactory receptor, family 52, subfamily K, member 2 |
chr22_+_23241661 | 5.99 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr20_+_54987168 | 5.86 |
ENST00000360314.3
|
CASS4
|
Cas scaffolding protein family member 4 |
chr19_-_42636543 | 5.86 |
ENST00000528894.4
ENST00000560804.2 ENST00000560558.1 ENST00000560398.1 ENST00000526816.2 |
POU2F2
|
POU class 2 homeobox 2 |
chr16_+_27438563 | 5.82 |
ENST00000395754.4
|
IL21R
|
interleukin 21 receptor |
chrX_+_48542168 | 5.80 |
ENST00000376701.4
|
WAS
|
Wiskott-Aldrich syndrome |
chrX_-_19688475 | 5.78 |
ENST00000541422.1
|
SH3KBP1
|
SH3-domain kinase binding protein 1 |
chr17_-_61776522 | 5.78 |
ENST00000582055.1
|
LIMD2
|
LIM domain containing 2 |
chr4_-_38806404 | 5.75 |
ENST00000308979.2
ENST00000505940.1 ENST00000515861.1 |
TLR1
|
toll-like receptor 1 |
chrX_+_135730297 | 5.72 |
ENST00000370629.2
|
CD40LG
|
CD40 ligand |
chr8_-_126963417 | 5.67 |
ENST00000500989.2
|
LINC00861
|
long intergenic non-protein coding RNA 861 |
chr17_-_72542278 | 5.65 |
ENST00000330793.1
|
CD300C
|
CD300c molecule |
chr9_-_130541017 | 5.62 |
ENST00000314830.8
|
SH2D3C
|
SH2 domain containing 3C |
chr8_+_11351494 | 5.62 |
ENST00000259089.4
|
BLK
|
B lymphoid tyrosine kinase |
chr14_-_107013465 | 5.59 |
ENST00000390625.2
|
IGHV3-49
|
immunoglobulin heavy variable 3-49 |
chr20_+_62716348 | 5.58 |
ENST00000349451.3
|
OPRL1
|
opiate receptor-like 1 |
chr17_-_62009702 | 5.52 |
ENST00000006750.3
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
chr1_-_145715565 | 5.44 |
ENST00000369288.2
ENST00000369290.1 ENST00000401557.3 |
CD160
|
CD160 molecule |
chr11_+_35198243 | 5.42 |
ENST00000528455.1
|
CD44
|
CD44 molecule (Indian blood group) |
chr19_-_14785698 | 5.35 |
ENST00000344373.4
ENST00000595472.1 |
EMR3
|
egf-like module containing, mucin-like, hormone receptor-like 3 |
chr17_-_56494713 | 5.34 |
ENST00000407977.2
|
RNF43
|
ring finger protein 43 |
chr1_+_206643787 | 5.30 |
ENST00000367120.3
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon |
chr19_-_52255107 | 5.29 |
ENST00000595042.1
ENST00000304748.4 |
FPR1
|
formyl peptide receptor 1 |
chr2_-_90538397 | 5.27 |
ENST00000443397.3
|
RP11-685N3.1
|
Uncharacterized protein |
chr5_-_138725594 | 5.25 |
ENST00000302125.8
|
MZB1
|
marginal zone B and B1 cell-specific protein |
chr1_+_168545711 | 5.23 |
ENST00000367818.3
|
XCL1
|
chemokine (C motif) ligand 1 |
chr3_+_113251143 | 5.19 |
ENST00000264852.4
ENST00000393830.3 |
SIDT1
|
SID1 transmembrane family, member 1 |
chr2_+_90153696 | 5.17 |
ENST00000417279.2
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
chrX_+_135730373 | 5.16 |
ENST00000370628.2
|
CD40LG
|
CD40 ligand |
chr1_-_173174681 | 5.14 |
ENST00000367718.1
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4 |
chr2_+_87565634 | 5.13 |
ENST00000421835.2
|
IGKV3OR2-268
|
immunoglobulin kappa variable 3/OR2-268 (non-functional) |
chr20_+_36932521 | 5.12 |
ENST00000262865.4
|
BPI
|
bactericidal/permeability-increasing protein |
chr16_+_72088376 | 5.11 |
ENST00000570083.1
ENST00000355906.5 ENST00000398131.2 ENST00000569639.1 ENST00000564499.1 ENST00000357763.4 ENST00000562526.1 ENST00000565574.1 ENST00000568417.2 ENST00000356967.5 |
HP
HPR
|
haptoglobin haptoglobin-related protein |
chr16_+_30194916 | 5.10 |
ENST00000570045.1
ENST00000565497.1 ENST00000570244.1 |
CORO1A
|
coronin, actin binding protein, 1A |
chr11_+_35198118 | 5.09 |
ENST00000525211.1
ENST00000526000.1 ENST00000279452.6 ENST00000527889.1 |
CD44
|
CD44 molecule (Indian blood group) |
chr4_-_109087445 | 5.07 |
ENST00000512172.1
|
LEF1
|
lymphoid enhancer-binding factor 1 |
chr19_-_14785622 | 5.04 |
ENST00000443157.2
|
EMR3
|
egf-like module containing, mucin-like, hormone receptor-like 3 |
chr5_+_156607829 | 4.98 |
ENST00000422843.3
|
ITK
|
IL2-inducible T-cell kinase |
chr5_-_138725560 | 4.95 |
ENST00000412103.2
ENST00000457570.2 |
MZB1
|
marginal zone B and B1 cell-specific protein |
chr2_+_89890533 | 4.94 |
ENST00000429992.2
|
IGKV2D-40
|
immunoglobulin kappa variable 2D-40 |
chr12_-_9760482 | 4.94 |
ENST00000229402.3
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1 |
chr19_-_50868882 | 4.91 |
ENST00000598915.1
|
NAPSA
|
napsin A aspartic peptidase |
chr2_-_89327228 | 4.89 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
chr4_-_109087906 | 4.88 |
ENST00000515500.1
|
LEF1
|
lymphoid enhancer-binding factor 1 |
chr14_-_107179265 | 4.85 |
ENST00000390634.2
|
IGHV2-70
|
immunoglobulin heavy variable 2-70 |
chr12_+_47610315 | 4.84 |
ENST00000548348.1
ENST00000549500.1 |
PCED1B
|
PC-esterase domain containing 1B |
chr20_+_54987305 | 4.84 |
ENST00000371336.3
ENST00000434344.1 |
CASS4
|
Cas scaffolding protein family member 4 |
chr3_-_112218205 | 4.76 |
ENST00000383680.4
|
BTLA
|
B and T lymphocyte associated |
chr3_-_112218378 | 4.75 |
ENST00000334529.5
|
BTLA
|
B and T lymphocyte associated |
chr8_-_21771173 | 4.75 |
ENST00000518197.1
|
DOK2
|
docking protein 2, 56kDa |
chr19_+_55417530 | 4.71 |
ENST00000350790.5
ENST00000338835.5 ENST00000357397.5 |
NCR1
|
natural cytotoxicity triggering receptor 1 |
chr17_-_7017559 | 4.70 |
ENST00000446679.2
|
ASGR2
|
asialoglycoprotein receptor 2 |
chr3_-_71834318 | 4.70 |
ENST00000353065.3
|
PROK2
|
prokineticin 2 |
chr12_-_103889731 | 4.69 |
ENST00000552578.1
ENST00000548048.1 ENST00000315192.8 ENST00000548883.1 ENST00000378113.2 |
C12orf42
|
chromosome 12 open reading frame 42 |
chr1_-_207095212 | 4.68 |
ENST00000420007.2
|
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
chr6_+_45296048 | 4.65 |
ENST00000465038.2
ENST00000352853.5 ENST00000541979.1 ENST00000371438.1 |
RUNX2
|
runt-related transcription factor 2 |
chr19_-_14785674 | 4.64 |
ENST00000253673.5
|
EMR3
|
egf-like module containing, mucin-like, hormone receptor-like 3 |
chr18_-_68317947 | 4.64 |
ENST00000594039.1
ENST00000582578.1 |
GTSCR1
|
Gilles de la Tourette syndrome chromosome region, candidate 1 |
chr2_-_89385283 | 4.62 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
chr22_+_24823517 | 4.60 |
ENST00000496258.1
ENST00000337539.7 |
ADORA2A
|
adenosine A2a receptor |
chr1_-_1690014 | 4.60 |
ENST00000400922.2
ENST00000342348.5 |
NADK
|
NAD kinase |
chr1_-_235098935 | 4.59 |
ENST00000423175.1
|
RP11-443B7.1
|
RP11-443B7.1 |
chr2_+_89196746 | 4.56 |
ENST00000390244.2
|
IGKV5-2
|
immunoglobulin kappa variable 5-2 |
chr2_+_30455016 | 4.56 |
ENST00000401506.1
ENST00000407930.2 |
LBH
|
limb bud and heart development |
chr11_+_65647280 | 4.54 |
ENST00000307886.3
ENST00000528419.1 ENST00000526034.1 |
CTSW
|
cathepsin W |
chr14_+_21359558 | 4.51 |
ENST00000304639.3
|
RNASE3
|
ribonuclease, RNase A family, 3 |
chr3_-_72149553 | 4.50 |
ENST00000468646.2
ENST00000464271.1 |
LINC00877
|
long intergenic non-protein coding RNA 877 |
chr11_-_58345569 | 4.47 |
ENST00000528954.1
ENST00000528489.1 |
LPXN
|
leupaxin |
chr20_+_44637526 | 4.45 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
chr17_+_7239821 | 4.44 |
ENST00000158762.3
ENST00000570457.2 |
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr19_+_52255261 | 4.41 |
ENST00000600258.1
|
FPR2
|
formyl peptide receptor 2 |
chr22_+_22786288 | 4.40 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
chrX_-_70331298 | 4.39 |
ENST00000456850.2
ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG
|
interleukin 2 receptor, gamma |
chr3_+_186692745 | 4.39 |
ENST00000438590.1
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
chr1_+_206643806 | 4.38 |
ENST00000537984.1
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon |
chr17_+_7239904 | 4.38 |
ENST00000575425.1
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr14_+_22670455 | 4.37 |
ENST00000390460.1
|
TRAV26-2
|
T cell receptor alpha variable 26-2 |
chr14_+_22386325 | 4.36 |
ENST00000390439.2
|
TRAV13-2
|
T cell receptor alpha variable 13-2 |
chr1_+_90098606 | 4.36 |
ENST00000370454.4
|
LRRC8C
|
leucine rich repeat containing 8 family, member C |
chr22_+_22707260 | 4.30 |
ENST00000390293.1
|
IGLV5-48
|
immunoglobulin lambda variable 5-48 (non-functional) |
chr14_+_22788560 | 4.28 |
ENST00000390468.1
|
TRAV41
|
T cell receptor alpha variable 41 |
chr2_+_90211643 | 4.25 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
chr7_-_36634181 | 4.23 |
ENST00000538464.1
|
AOAH
|
acyloxyacyl hydrolase (neutrophil) |
chr5_-_94417562 | 4.23 |
ENST00000505465.1
|
MCTP1
|
multiple C2 domains, transmembrane 1 |
chr1_-_157522260 | 4.21 |
ENST00000368191.3
ENST00000361835.3 |
FCRL5
|
Fc receptor-like 5 |
chr7_-_142176790 | 4.20 |
ENST00000390369.2
|
TRBV7-4
|
T cell receptor beta variable 7-4 (gene/pseudogene) |
chr7_-_142207004 | 4.20 |
ENST00000426318.2
|
TRBV10-2
|
T cell receptor beta variable 10-2 |
chr2_+_68592305 | 4.19 |
ENST00000234313.7
|
PLEK
|
pleckstrin |
chr2_-_89278535 | 4.18 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
chr8_+_27168988 | 4.17 |
ENST00000397501.1
ENST00000338238.4 ENST00000544172.1 |
PTK2B
|
protein tyrosine kinase 2 beta |
chrX_+_37639302 | 4.17 |
ENST00000545017.1
ENST00000536160.1 |
CYBB
|
cytochrome b-245, beta polypeptide |
chr20_-_1569278 | 4.14 |
ENST00000262929.5
ENST00000567028.1 |
SIRPB1
RP4-576H24.4
|
signal-regulatory protein beta 1 Uncharacterized protein |
chr1_-_207095324 | 4.14 |
ENST00000530505.1
ENST00000367091.3 ENST00000442471.2 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
chr6_-_154568815 | 4.12 |
ENST00000519344.1
|
IPCEF1
|
interaction protein for cytohesin exchange factors 1 |
chr22_+_24038593 | 4.12 |
ENST00000452208.1
|
RGL4
|
ral guanine nucleotide dissociation stimulator-like 4 |
chr5_-_43043272 | 4.10 |
ENST00000314890.3
|
ANXA2R
|
annexin A2 receptor |
chr21_+_30502806 | 4.10 |
ENST00000399928.1
ENST00000399926.1 |
MAP3K7CL
|
MAP3K7 C-terminal like |
chr19_-_52133588 | 4.10 |
ENST00000570106.2
|
SIGLEC5
|
sialic acid binding Ig-like lectin 5 |
chr1_+_53098862 | 4.08 |
ENST00000517870.1
|
FAM159A
|
family with sequence similarity 159, member A |
chr1_-_157522180 | 4.07 |
ENST00000356953.4
ENST00000368188.2 ENST00000368190.3 ENST00000368189.3 |
FCRL5
|
Fc receptor-like 5 |
chr14_+_22919081 | 4.02 |
ENST00000390473.1
|
TRDJ1
|
T cell receptor delta joining 1 |
chr2_+_103035102 | 4.01 |
ENST00000264260.2
|
IL18RAP
|
interleukin 18 receptor accessory protein |
chr11_-_128457446 | 3.99 |
ENST00000392668.4
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
chr20_-_62199427 | 3.97 |
ENST00000427522.2
|
HELZ2
|
helicase with zinc finger 2, transcriptional coactivator |
chr8_-_21771214 | 3.97 |
ENST00000276420.4
|
DOK2
|
docking protein 2, 56kDa |
chr2_-_73869508 | 3.96 |
ENST00000272425.3
|
NAT8
|
N-acetyltransferase 8 (GCN5-related, putative) |
chr4_-_109087872 | 3.94 |
ENST00000510624.1
|
LEF1
|
lymphoid enhancer-binding factor 1 |
chr18_-_67629015 | 3.93 |
ENST00000579496.1
|
CD226
|
CD226 molecule |
chr19_-_52150053 | 3.87 |
ENST00000599649.1
ENST00000429354.3 ENST00000360844.6 ENST00000222107.4 |
SIGLEC5
SIGLEC14
SIGLEC5
|
SIGLEC5 sialic acid binding Ig-like lectin 14 sialic acid binding Ig-like lectin 5 |
chr7_+_99971129 | 3.87 |
ENST00000394000.2
ENST00000350573.2 |
PILRA
|
paired immunoglobin-like type 2 receptor alpha |
chr11_+_121447469 | 3.85 |
ENST00000532694.1
ENST00000534286.1 |
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
chr14_-_106092403 | 3.82 |
ENST00000390543.2
|
IGHG4
|
immunoglobulin heavy constant gamma 4 (G4m marker) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.3 | 25.0 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
5.0 | 15.0 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
3.9 | 15.7 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
3.7 | 29.8 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
3.5 | 14.2 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
3.4 | 13.4 | GO:0071661 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
3.0 | 12.0 | GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) positive regulation of protein K63-linked ubiquitination(GO:1902523) |
3.0 | 11.9 | GO:0002432 | granuloma formation(GO:0002432) |
2.9 | 8.8 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
2.9 | 14.4 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
2.6 | 47.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
2.4 | 7.3 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
2.4 | 7.3 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
2.2 | 6.5 | GO:0002818 | intracellular defense response(GO:0002818) |
2.1 | 6.3 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
2.0 | 15.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
2.0 | 13.9 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
2.0 | 7.9 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
2.0 | 7.9 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
1.9 | 3.8 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
1.8 | 5.4 | GO:1902960 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
1.7 | 5.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.7 | 5.1 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
1.6 | 4.8 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
1.6 | 15.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
1.5 | 29.3 | GO:0043383 | negative T cell selection(GO:0043383) |
1.5 | 6.1 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
1.5 | 4.5 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
1.5 | 7.5 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
1.4 | 5.8 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
1.4 | 7.2 | GO:0039650 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
1.4 | 5.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.3 | 7.9 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
1.3 | 7.7 | GO:2000537 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
1.2 | 3.6 | GO:1903216 | negative regulation of late endosome to lysosome transport(GO:1902823) regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
1.2 | 4.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.2 | 5.8 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
1.2 | 10.5 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
1.2 | 3.5 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
1.2 | 1.2 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
1.2 | 2.3 | GO:0060389 | pathway-restricted SMAD protein phosphorylation(GO:0060389) |
1.1 | 2.3 | GO:2000452 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
1.1 | 1.1 | GO:0002859 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
1.1 | 12.3 | GO:0070269 | pyroptosis(GO:0070269) |
1.1 | 13.0 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.1 | 11.7 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
1.1 | 6.3 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
1.0 | 2.1 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
1.0 | 16.4 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
1.0 | 5.1 | GO:0061502 | uropod organization(GO:0032796) early endosome to recycling endosome transport(GO:0061502) |
1.0 | 2.0 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
1.0 | 4.9 | GO:1904882 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
1.0 | 2.9 | GO:1904604 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
0.9 | 17.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.9 | 6.4 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.9 | 2.7 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.9 | 2.7 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.9 | 4.5 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.9 | 3.5 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.9 | 2.7 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.9 | 3.5 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.9 | 2.6 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.8 | 3.3 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
0.8 | 8.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.8 | 2.5 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.8 | 16.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.8 | 4.0 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.8 | 7.9 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.8 | 0.8 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
0.8 | 6.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.8 | 3.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.7 | 5.2 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.7 | 3.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.7 | 2.2 | GO:2000627 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
0.7 | 4.4 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.7 | 6.6 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.7 | 29.1 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.7 | 9.3 | GO:0002855 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.7 | 16.9 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.7 | 2.1 | GO:0035700 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
0.7 | 2.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.7 | 2.7 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.7 | 2.0 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.7 | 4.7 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.7 | 8.7 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.7 | 2.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.7 | 4.6 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.7 | 2.0 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.6 | 3.2 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.6 | 1.9 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.6 | 1.3 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.6 | 3.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.6 | 1.2 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
0.6 | 3.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.6 | 6.5 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.6 | 90.7 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.6 | 10.3 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.6 | 4.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.6 | 2.2 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.6 | 5.6 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.6 | 1.7 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.5 | 27.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.5 | 1.6 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
0.5 | 6.4 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.5 | 2.1 | GO:0052363 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.5 | 2.7 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.5 | 3.1 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.5 | 4.7 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.5 | 2.1 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.5 | 7.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.5 | 11.8 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.5 | 1.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.5 | 3.6 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.5 | 1.5 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
0.5 | 4.0 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.5 | 2.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.5 | 1.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.5 | 2.0 | GO:0050705 | negative regulation of interleukin-1 alpha production(GO:0032690) regulation of interleukin-1 alpha secretion(GO:0050705) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.5 | 4.9 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.5 | 40.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.5 | 1.9 | GO:1900148 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
0.5 | 1.4 | GO:1901656 | cellular response to mycotoxin(GO:0036146) glycoside transport(GO:1901656) cellular response to bile acid(GO:1903413) |
0.5 | 1.4 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.5 | 1.9 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.5 | 9.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.5 | 102.5 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.5 | 1.4 | GO:0032824 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.5 | 8.7 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.5 | 3.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.5 | 1.8 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.5 | 1.4 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
0.5 | 1.4 | GO:0045925 | positive regulation of female receptivity(GO:0045925) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.4 | 1.8 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.4 | 3.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.4 | 1.8 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.4 | 3.1 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.4 | 2.2 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.4 | 9.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.4 | 2.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.4 | 1.7 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
0.4 | 7.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.4 | 12.5 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
0.4 | 6.2 | GO:0072678 | T cell migration(GO:0072678) |
0.4 | 0.8 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.4 | 0.4 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
0.4 | 1.6 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.4 | 1.2 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.4 | 1.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.4 | 5.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.4 | 36.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.4 | 1.2 | GO:1990637 | response to prolactin(GO:1990637) |
0.4 | 2.3 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.4 | 1.2 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.4 | 1.6 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
0.4 | 1.6 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.4 | 1.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.4 | 1.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.4 | 3.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.4 | 1.5 | GO:0050707 | regulation of cytokine secretion(GO:0050707) |
0.4 | 3.7 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.4 | 1.9 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.4 | 1.5 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.4 | 10.7 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.4 | 1.1 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.4 | 2.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.4 | 1.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.4 | 1.4 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.4 | 1.4 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.4 | 1.1 | GO:1902004 | regulation of beta-amyloid formation(GO:1902003) positive regulation of beta-amyloid formation(GO:1902004) |
0.3 | 1.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 1.7 | GO:1905071 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
0.3 | 2.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.3 | 4.9 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.3 | 1.0 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.3 | 1.0 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.3 | 0.3 | GO:0035566 | regulation of metanephros size(GO:0035566) |
0.3 | 8.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.3 | 5.5 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.3 | 1.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.3 | 2.2 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.3 | 0.9 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
0.3 | 0.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 4.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 6.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.3 | 2.1 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.3 | 0.9 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.3 | 1.2 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.3 | 2.4 | GO:0046618 | drug export(GO:0046618) |
0.3 | 1.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 1.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.3 | 1.2 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.3 | 3.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.3 | 1.7 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.3 | 4.0 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.3 | 3.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.3 | 1.1 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.3 | 0.3 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
0.3 | 3.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.3 | 0.8 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
0.3 | 1.4 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.3 | 1.3 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.3 | 0.8 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
0.3 | 1.8 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.3 | 1.0 | GO:0071348 | response to interleukin-11(GO:0071105) cellular response to interleukin-11(GO:0071348) |
0.3 | 1.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.3 | 1.5 | GO:0019050 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) |
0.3 | 0.8 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
0.2 | 3.0 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 1.0 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
0.2 | 4.7 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.2 | 3.0 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.2 | 3.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.2 | 1.2 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.2 | 2.9 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.2 | 2.4 | GO:0038129 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
0.2 | 0.7 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.2 | 1.7 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.2 | 2.6 | GO:0032264 | IMP salvage(GO:0032264) |
0.2 | 2.6 | GO:0002507 | tolerance induction(GO:0002507) |
0.2 | 0.7 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.2 | 3.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 1.2 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.2 | 0.9 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.2 | 16.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 11.6 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.2 | 1.6 | GO:0043144 | snoRNA processing(GO:0043144) |
0.2 | 1.6 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
0.2 | 4.1 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.2 | 0.9 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.2 | 1.1 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
0.2 | 9.1 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.2 | 15.5 | GO:0031295 | T cell costimulation(GO:0031295) |
0.2 | 2.3 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.2 | 0.7 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.2 | 2.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.2 | 1.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.2 | 3.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 3.9 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 1.9 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.2 | 0.9 | GO:0060022 | hard palate development(GO:0060022) |
0.2 | 5.1 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.2 | 6.5 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.2 | 4.4 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 2.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 0.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 2.3 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.2 | 0.6 | GO:0070839 | spleen trabecula formation(GO:0060345) divalent metal ion export(GO:0070839) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
0.2 | 7.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 1.6 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 0.8 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.2 | 5.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 3.4 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.2 | 0.6 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 0.4 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
0.2 | 5.8 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.2 | 1.4 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.2 | 4.2 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.2 | 2.1 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
0.2 | 3.2 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.2 | 0.9 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 2.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 1.3 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.2 | 0.6 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 0.5 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
0.2 | 0.7 | GO:0050992 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
0.2 | 2.0 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
0.2 | 0.5 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.2 | 0.7 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.2 | 5.3 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.2 | 2.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 2.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 0.5 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.2 | 1.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.9 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 1.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.2 | 6.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 2.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 0.8 | GO:0007584 | response to nutrient(GO:0007584) |
0.2 | 1.6 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.2 | 0.5 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.2 | 3.4 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.2 | 0.8 | GO:0045007 | depurination(GO:0045007) |
0.2 | 2.4 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.2 | 3.0 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 0.5 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
0.2 | 3.0 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 5.9 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.2 | 1.1 | GO:0007172 | signal complex assembly(GO:0007172) |
0.2 | 1.2 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.2 | 0.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 0.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 1.4 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.2 | 0.8 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 0.9 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.1 | 0.1 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.1 | 0.9 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.1 | 1.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 1.5 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.1 | 0.7 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.6 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 2.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 3.1 | GO:0072574 | hepatocyte proliferation(GO:0072574) epithelial cell proliferation involved in liver morphogenesis(GO:0072575) |
0.1 | 8.2 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) negative regulation of leukocyte proliferation(GO:0070664) |
0.1 | 2.8 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.8 | GO:0043585 | nose morphogenesis(GO:0043585) alveolar primary septum development(GO:0061143) |
0.1 | 3.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 1.3 | GO:0046075 | dTTP metabolic process(GO:0046075) |
0.1 | 0.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.4 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.1 | 1.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 2.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 1.9 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 0.9 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 1.0 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 1.3 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
0.1 | 0.3 | GO:0002501 | MHC protein complex assembly(GO:0002396) peptide antigen assembly with MHC protein complex(GO:0002501) |
0.1 | 0.4 | GO:1903708 | positive regulation of hemopoiesis(GO:1903708) |
0.1 | 2.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.9 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 3.4 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.4 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.9 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.1 | 3.4 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 0.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 2.2 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.1 | 8.5 | GO:0070671 | interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
0.1 | 83.3 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.1 | 0.8 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.1 | 0.4 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 1.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 5.5 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.3 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
0.1 | 0.9 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 4.6 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.8 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.1 | 0.7 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.5 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 1.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.6 | GO:0010816 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.1 | 0.8 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.1 | 1.4 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 1.7 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 2.7 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.4 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.1 | 0.2 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.1 | 7.7 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 3.7 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.1 | 0.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.9 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.1 | 0.9 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 1.4 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.7 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 1.9 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 1.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 9.7 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.8 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 2.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.9 | GO:1902363 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.1 | 1.9 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.8 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 0.6 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 1.1 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 5.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 1.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.6 | GO:0015887 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
0.1 | 0.3 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
0.1 | 0.9 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 1.7 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.7 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.8 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 6.4 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.1 | 9.9 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 0.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.5 | GO:0048565 | digestive tract development(GO:0048565) |
0.1 | 0.4 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.6 | GO:0015677 | copper ion import(GO:0015677) |
0.1 | 5.8 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.1 | 3.0 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 3.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 1.6 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.1 | 1.8 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.1 | 1.2 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.1 | 0.5 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.6 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.1 | 0.8 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.1 | 2.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 3.9 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.3 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 1.7 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 3.0 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.1 | 10.3 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.1 | 0.2 | GO:0050894 | determination of affect(GO:0050894) |
0.1 | 0.4 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 11.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.9 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 3.6 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 3.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.8 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 1.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.7 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.4 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.6 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 0.5 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.1 | 2.5 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.1 | 0.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
0.1 | 0.6 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 1.0 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.1 | 3.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 3.0 | GO:0030155 | regulation of cell adhesion(GO:0030155) |
0.1 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.4 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.8 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.1 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.1 | GO:0042245 | RNA repair(GO:0042245) |
0.1 | 0.6 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.1 | 0.1 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.1 | 0.1 | GO:0060700 | regulation of endoribonuclease activity(GO:0060699) regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.2 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
0.1 | 0.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 1.6 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.4 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.3 | GO:0035745 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 0.5 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.1 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 1.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 1.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.9 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.6 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.5 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 1.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.2 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.0 | 1.1 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.0 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.4 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 1.8 | GO:0046464 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.0 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 1.1 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.0 | 0.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.7 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.1 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.0 | 0.3 | GO:0019075 | virus maturation(GO:0019075) |
0.0 | 0.8 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.4 | GO:0044211 | CTP salvage(GO:0044211) |
0.0 | 0.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.9 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
0.0 | 0.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.0 | 0.7 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 1.2 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.7 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 1.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 1.3 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 1.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 3.0 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.0 | 0.4 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.0 | 1.9 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.5 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.0 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.6 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.7 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 1.0 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.4 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.1 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.0 | 2.0 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.0 | 0.1 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.0 | 0.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.0 | 2.4 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 1.0 | GO:0015879 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.0 | 0.1 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
0.0 | 0.1 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.0 | 0.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 1.3 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 4.9 | GO:0018393 | internal peptidyl-lysine acetylation(GO:0018393) |
0.0 | 0.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.5 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 1.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.2 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) negative regulation of telomerase activity(GO:0051974) |
0.0 | 3.2 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 0.6 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 1.4 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 1.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
0.0 | 3.0 | GO:0031929 | TOR signaling(GO:0031929) |
0.0 | 0.3 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.3 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.0 | 0.5 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.0 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
0.0 | 0.1 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.0 | 0.4 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.0 | 0.9 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.0 | 0.4 | GO:0051262 | protein tetramerization(GO:0051262) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.1 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.0 | 0.8 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.5 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.0 | 0.3 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.8 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.6 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.0 | 1.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.4 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.0 | 1.2 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.9 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.5 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.0 | 0.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.3 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.0 | 0.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.0 | 0.5 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.4 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.4 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 17.1 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.1 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
0.0 | 1.1 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.3 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 0.2 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.1 | GO:0036260 | 7-methylguanosine mRNA capping(GO:0006370) 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.5 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.0 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 2.3 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.0 | 0.6 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.7 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 0.1 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.0 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.1 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.5 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 0.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.4 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 0.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.3 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.7 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.4 | GO:0002223 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 14.4 | GO:0071749 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
2.9 | 14.4 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
2.2 | 8.8 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
1.8 | 12.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.6 | 59.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.5 | 4.5 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
1.4 | 9.6 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
1.3 | 10.5 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
1.1 | 2.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.1 | 14.9 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.0 | 4.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.0 | 27.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.9 | 6.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.9 | 6.4 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.9 | 3.6 | GO:0044753 | amphisome(GO:0044753) |
0.9 | 2.6 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
0.8 | 7.6 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.7 | 14.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.7 | 2.2 | GO:0097447 | dendritic tree(GO:0097447) |
0.7 | 42.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.7 | 0.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.7 | 2.1 | GO:0036398 | TCR signalosome(GO:0036398) |
0.7 | 6.0 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.7 | 7.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.6 | 30.8 | GO:0042571 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.6 | 14.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.6 | 2.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.5 | 2.1 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.5 | 4.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.5 | 2.5 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.5 | 15.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 3.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.5 | 56.0 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.5 | 1.9 | GO:0031251 | PAN complex(GO:0031251) |
0.4 | 2.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
0.4 | 9.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.4 | 2.5 | GO:1990037 | Lewy body core(GO:1990037) |
0.4 | 5.4 | GO:0044754 | autolysosome(GO:0044754) |
0.4 | 0.8 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.3 | 8.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 31.1 | GO:0035580 | specific granule lumen(GO:0035580) |
0.3 | 3.8 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 1.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.3 | 2.5 | GO:0031415 | NatA complex(GO:0031415) |
0.3 | 109.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 1.5 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
0.3 | 6.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 3.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 4.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 4.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 2.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.3 | 6.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 2.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 8.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.3 | 0.5 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 1.5 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 1.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 1.4 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.2 | 1.5 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 25.5 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.2 | 18.1 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.2 | 0.6 | GO:0071062 | rough endoplasmic reticulum lumen(GO:0048237) alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 12.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 2.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 7.9 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.2 | 6.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 3.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 1.2 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.2 | 7.4 | GO:0031105 | septin complex(GO:0031105) |
0.2 | 0.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 3.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 1.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 2.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 36.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 4.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 2.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 1.6 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 2.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 1.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 13.6 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 1.8 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 1.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 1.4 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.4 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.1 | 1.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 1.9 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 1.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 1.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 1.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 3.9 | GO:0005903 | brush border(GO:0005903) |
0.1 | 9.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 6.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 31.7 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.3 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.1 | 0.9 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 1.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 1.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 2.7 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 1.2 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 4.5 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 1.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.6 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 1.0 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.8 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.5 | GO:0070701 | mucus layer(GO:0070701) |
0.1 | 0.7 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 1.9 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 1.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 6.1 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.9 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 4.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.9 | GO:0055028 | cortical microtubule(GO:0055028) |
0.1 | 1.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.4 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 13.5 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.1 | 9.3 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.8 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.1 | 1.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.9 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 3.1 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 2.1 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 13.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 1.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.3 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.1 | 0.5 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 1.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.8 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 2.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 1.2 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 4.5 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 6.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 1.7 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 3.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.6 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 1.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 2.7 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 1.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 5.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 1.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 1.5 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 9.9 | GO:0016605 | PML body(GO:0016605) |
0.1 | 1.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.3 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 2.3 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 1.0 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 0.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 4.9 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 10.5 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.4 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 22.4 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 1.7 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.8 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 0.6 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.3 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 6.3 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 2.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 1.3 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.3 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 1.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 8.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 2.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.1 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.0 | 0.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.1 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.0 | 4.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.4 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 2.2 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 3.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.4 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.4 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.9 | GO:0000792 | heterochromatin(GO:0000792) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 1.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.5 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 1.0 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 2.4 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 2.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 1.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 1.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.2 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 1.0 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.9 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 0.1 | GO:0038201 | TOR complex(GO:0038201) |
0.0 | 1.5 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.0 | 1.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 9.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 1.2 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.7 | GO:0018995 | host(GO:0018995) host cell(GO:0043657) |
0.0 | 0.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.3 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 43.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
4.2 | 25.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
3.6 | 10.9 | GO:0005174 | CD40 receptor binding(GO:0005174) |
3.2 | 12.9 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
2.3 | 9.0 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
2.2 | 11.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
1.8 | 8.8 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
1.6 | 8.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.6 | 4.8 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
1.5 | 4.5 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
1.4 | 13.8 | GO:0030882 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
1.4 | 6.8 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
1.3 | 5.1 | GO:0048030 | disaccharide binding(GO:0048030) |
1.3 | 7.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.3 | 9.0 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
1.3 | 10.2 | GO:0005124 | scavenger receptor binding(GO:0005124) |
1.2 | 3.6 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
1.2 | 4.8 | GO:0019862 | IgA binding(GO:0019862) |
1.2 | 5.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.0 | 3.1 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
1.0 | 2.9 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
1.0 | 2.9 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
1.0 | 2.9 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.9 | 12.0 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.9 | 2.7 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.9 | 4.4 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.9 | 6.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.9 | 7.9 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.9 | 5.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.9 | 13.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.9 | 5.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.8 | 5.1 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.8 | 10.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.8 | 5.0 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.8 | 2.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.8 | 7.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.8 | 5.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.8 | 2.3 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.8 | 13.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.7 | 2.2 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
0.7 | 0.7 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
0.7 | 177.5 | GO:0003823 | antigen binding(GO:0003823) |
0.7 | 19.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.7 | 4.7 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.7 | 3.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.6 | 29.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.6 | 5.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.6 | 5.5 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.6 | 5.4 | GO:0004875 | complement receptor activity(GO:0004875) |
0.6 | 1.8 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
0.6 | 17.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.6 | 10.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.6 | 1.7 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.5 | 4.9 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.5 | 3.3 | GO:0045569 | TRAIL binding(GO:0045569) |
0.5 | 10.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.5 | 1.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.5 | 17.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.5 | 3.5 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.5 | 20.0 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.5 | 6.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.5 | 19.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.5 | 5.5 | GO:0019864 | IgG binding(GO:0019864) |
0.4 | 45.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 4.4 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.4 | 1.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.4 | 1.7 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.4 | 4.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.4 | 1.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.4 | 1.6 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.4 | 1.2 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
0.4 | 1.2 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.4 | 5.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 2.0 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.4 | 1.6 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.4 | 1.9 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.4 | 7.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.4 | 4.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.4 | 1.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.4 | 1.5 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.4 | 5.9 | GO:0045159 | myosin II binding(GO:0045159) |
0.4 | 4.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.4 | 1.1 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.4 | 8.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.4 | 3.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.4 | 1.4 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.3 | 1.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 3.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 1.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.3 | 0.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 7.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 7.0 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 1.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 4.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 1.2 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.3 | 2.1 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.3 | 2.9 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.3 | 2.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 2.0 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.3 | 3.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 0.8 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.3 | 1.4 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.3 | 1.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.3 | 1.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 1.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 2.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.3 | 2.4 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.3 | 3.9 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.3 | 1.6 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.3 | 1.8 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.3 | 2.0 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 5.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 1.0 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
0.2 | 6.7 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 2.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 1.2 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.2 | 1.4 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.2 | 2.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 0.9 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.2 | 2.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 0.7 | GO:0031626 | beta-endorphin binding(GO:0031626) |
0.2 | 0.7 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.2 | 4.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 7.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 3.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 3.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 5.1 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.2 | 4.0 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.2 | 0.9 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 5.5 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 8.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 5.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 1.9 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.2 | 3.9 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.2 | 4.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 1.5 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.2 | 6.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 8.9 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.2 | 4.4 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 0.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 0.6 | GO:0097689 | iron channel activity(GO:0097689) |
0.2 | 0.8 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.2 | 1.0 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 6.7 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.2 | 0.6 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.2 | 2.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 8.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.8 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.2 | 6.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 2.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 2.6 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 2.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 8.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 2.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 19.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 0.6 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
0.2 | 0.5 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
0.2 | 0.7 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.2 | 3.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 4.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 2.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 5.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 5.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 1.0 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.5 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.2 | 1.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 0.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 0.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 1.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.2 | 1.3 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.2 | 2.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 7.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.3 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.2 | 1.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 2.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 6.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 3.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.2 | GO:0004180 | carboxypeptidase activity(GO:0004180) metallocarboxypeptidase activity(GO:0004181) |
0.2 | 3.4 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 0.9 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.7 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 0.7 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 2.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 5.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 5.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 3.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 1.9 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 1.6 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 1.5 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 2.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 4.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.8 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.1 | 11.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 2.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 1.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 2.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 2.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 2.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 2.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 1.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 1.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 2.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 1.5 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 4.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 9.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 1.0 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.7 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.1 | 0.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.3 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 0.3 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.1 | 2.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.3 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.1 | 1.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.6 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.1 | 2.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.7 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 0.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 1.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.5 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
0.1 | 2.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 5.5 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.1 | 4.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.2 | GO:0033677 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) DNA/RNA helicase activity(GO:0033677) |
0.1 | 2.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 1.6 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.4 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 0.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.9 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 1.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 1.4 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.1 | 2.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.6 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.1 | 0.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.4 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 1.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 2.0 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 1.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 1.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 4.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.6 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 18.4 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.3 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.1 | 3.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 9.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.8 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 1.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 1.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 1.0 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 2.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.6 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 9.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 1.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.2 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.1 | 6.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.4 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 2.0 | GO:0070001 | aspartic-type peptidase activity(GO:0070001) |
0.1 | 1.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.6 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.1 | 0.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 2.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 2.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.5 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 3.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.6 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 5.3 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.1 | 0.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 2.0 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.2 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.1 | 0.9 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.2 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.1 | 0.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 19.8 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.4 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 13.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 29.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 1.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 1.0 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 5.5 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.7 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 3.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.5 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.0 | 0.6 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.7 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 1.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.6 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 2.0 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 1.5 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.0 | 1.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 2.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.5 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.0 | 2.5 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 1.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 6.5 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 1.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 1.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 2.1 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.5 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
0.0 | 0.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.1 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.0 | 0.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 2.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.4 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.0 | 0.3 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 0.1 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.0 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 1.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.2 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 2.0 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 1.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.6 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 5.7 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 1.7 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 1.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.5 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.7 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.0 | 0.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 1.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.6 | GO:0009975 | adenylate cyclase activity(GO:0004016) guanylate cyclase activity(GO:0004383) cyclase activity(GO:0009975) |
0.0 | 1.5 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.1 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.2 | GO:0046914 | transition metal ion binding(GO:0046914) |
0.0 | 0.7 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.0 | 0.6 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 2.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 1.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 1.2 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 1.1 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 1.2 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.3 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.8 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.0 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.4 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.3 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 38.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.9 | 13.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.8 | 24.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.8 | 31.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.7 | 103.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.5 | 19.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.5 | 42.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.4 | 22.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 18.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 16.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 14.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 9.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 10.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 13.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 26.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 24.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 16.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 3.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 4.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 2.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 7.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 1.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 6.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 30.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 4.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 1.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 3.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 3.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 16.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 9.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 0.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 4.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 3.8 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 5.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 7.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 7.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 7.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 5.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.6 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 1.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 2.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 4.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 3.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 11.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 1.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 2.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 5.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.8 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 4.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 2.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 3.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 1.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 2.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 4.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 1.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 2.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 10.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 2.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 2.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 1.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 1.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 1.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.7 | PID PLK1 PATHWAY | PLK1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 55.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.0 | 35.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.0 | 32.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.8 | 18.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.8 | 17.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.7 | 21.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.7 | 53.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.7 | 40.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.6 | 13.9 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.5 | 59.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.5 | 11.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.5 | 6.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 10.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.5 | 7.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.5 | 11.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 4.9 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.3 | 10.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 19.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 19.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 13.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.3 | 6.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 14.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 5.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 2.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 8.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 12.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 11.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 2.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 9.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 7.4 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.2 | 3.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 6.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 5.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 2.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 10.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 2.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 5.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 2.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 2.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 1.7 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 14.4 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 3.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 3.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 5.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 2.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 3.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 2.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 2.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 3.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 5.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 2.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 4.8 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 26.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 4.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.7 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 1.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.8 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 1.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 3.1 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 7.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 0.4 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 4.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 3.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 2.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 1.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 2.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 4.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 4.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.2 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 4.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 6.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 15.2 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 1.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.9 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 1.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 1.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 1.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 4.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 1.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 1.6 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.0 | 0.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 4.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 1.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 1.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 3.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 2.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 1.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 1.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 1.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.4 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 1.4 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 2.0 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 1.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.6 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.6 | REACTOME METABOLISM OF PROTEINS | Genes involved in Metabolism of proteins |
0.0 | 0.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |